Pharma Mar, S.A.
PHMMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 10.6% | -19.5% | -14.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 95.3% | 93.9% | 93.1% | 92.8% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 12.1% | 2.9% | 26.5% | 45.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 14.9% | 0.7% | 25.1% | 40.4% |
| EPS Diluted | 1.49 | 0.064 | 2.73 | 5.13 |
| % Growth | 2,246.5% | -97.7% | -46.8% | – |
| Operating Cash Flow | $0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |